BIOREGENX, INC. Other General Expense
BIOREGENX, INC. (BRGX) reported Other General Expense of $190.33 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherGeneralExpense · last filed 2026-05-20
- BIOREGENX, INC. other general expense for the quarter ending 2026-03-31 was $190.33K, a 33.04% decline year-over-year.
- BIOREGENX, INC. other general expense for the quarter ending 2025-12-31 was $212.81K, a 26.12% decline year-over-year.
- BIOREGENX, INC. other general expense for the quarter ending 2025-09-30 was $182.64K, a 15.97% decline year-over-year.
- BIOREGENX, INC. other general expense for the quarter ending 2025-03-31 was $284.23K.
- BIOREGENX, INC. other general expense for fiscal 2025 was $793.14K, a 27.24% decline from fiscal 2024.
- BIOREGENX, INC. other general expense for fiscal 2024 was $1.09M.
| Period end | Other General Expense 3 month | Other General Expense 6 month | Other General Expense 9 month | Other General Expense 12 month |
|---|---|---|---|---|
| 2026-03-31 | $190.33K 10-Q · filed 2026-05-20 | $403.14K derived: sum of 2 quarters · filed 2026-05-20 | $585.79K derived: sum of 3 quarters · filed 2026-05-20 | |
| 2025-12-31 | $212.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $395.46K derived: sum of 2 quarters · filed 2026-04-15 | $793.14K 10-K · filed 2026-04-15 | |
| 2025-09-30 | $182.64K 10-Q · filed 2025-11-14 | $580.33K 10-Q · filed 2025-11-14 | ||
| 2025-03-31 | $284.23K 10-Q · filed 2026-05-20 | $572.29K derived: sum of 2 quarters · filed 2026-05-20 | $789.64K derived: sum of 3 quarters · filed 2026-05-20 | |
| 2024-12-31 | $288.06K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $505.41K derived: sum of 2 quarters · filed 2026-04-15 | $1.09M 10-K · filed 2026-04-15 | |
| 2024-09-30 | $217.35K 10-Q · filed 2025-11-14 | $802.00K 10-Q · filed 2025-11-14 |